ONO PHARMACEUTICAL CO., LTD.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Commitment removed

SBTI ID

40013524

Informations générales

Localisation

Japan

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

22/10/2020

Objectifs à court terme (Near-Term)

Engagement de réduction des émissions à horizon FY2030

Statut

Targets set

Classification

1.5°C

Année cible

FY2030

Progression vers l'objectif0%

2015 (année de référence)FY2030

Description complète des objectifs

Ono Pharmaceutical Co., Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 55% by FY2030 and 100% by FY2050 from a FY2017 base year. Ono Pharmaceutical Co., Ltd. also commits to reduce absolute scope 3 GHG emissions 30% by FY2030 and 60% by FY2050 from a FY2017 base year.

Net-Zero

Statut

Commitment removed

Business Ambition 1.5°C

Statut

BA1.5 member

Date d'engagement

01/11/2019

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

JP3197600004

LEI

529900G26L4NG4GFJZ86

Note

Expired commitment

Source : Science Based Targets initiative | Données publiques